The main objective of the Prinses Beatrix Spierfonds is to cure muscular disease. The aim of the funding round 'Towards therapy' is to fund scientific research that is an important next step towards a targeted therapy for people with a muscle disease.In this funding round, Rick Wansink, theme Nanomedicine, and Frank Walboomers, theme Reconstructive and regenerative medicine, have been awarded a 250.000 EUR grant of the Prinses Beatrix Spierfonds towards the study and elucidation of myotonic dystrophy, in a project entitled: Harmful RNA in myotonic dystrophy.
More information (only available in Dutch): link.
Related news items
Brain specific mutations may only explain sporadic Alzheimer's disease in very few cases20 August 2018
Alexander Hoischen, theme Infectious diseases and global health, and colleagues studied brain- and blood-DNA of sporadic early-onset Alzheimer’s disease (AD) patients, for somatic mutations in the known AD genes.read more
Poster prize Lars Damen at 10th European Elastin Meeting17 August 2018
At the 10th European Elastin Meeting, Lars Damen, theme Reconstructive and regenerative medicine, received the early-stage researcher award for his poster entitled “Development of tools to study the sulfation pattern of heparan sulfate involved in elastic fiber biology”.read more
Merel Ritskes member of the 3RCC Scientific Advisory Board8 August 2018
The 3RCC Scientific Advisory Board is responsible for providing scientific expertise to the 3RCC, evaluating grant applications and evaluating the progress and functioning of the center.read more